We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$3.15B
AUM Growth
+$209M
(+7.1%)
Cap. Flow
+$45.8M
Cap. Flow
% of AUM
1.45%
Top 10 Holdings %
Top 10 Hldgs %
50.35%
Holding
67
New
21
Increased
15
Reduced
10
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$121M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$117M |
| 3 |
Quest Diagnostics
DGX
|
+$104M |
| 4 |
Elevance Health
ELV
|
+$94.1M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$56.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$145M |
| 2 |
Pediatrix Medical
MD
|
+$76.9M |
| 3 |
Agilent Technologies
A
|
+$70.5M |
| 4 |
AbbVie
ABBV
|
+$54.3M |
| 5 |
IQVIA
IQV
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Universal Health Services
UHS
$9.88B
| $48.8M | 1.55% |
+437,620
| New | +$51.3M |
|
|
XENT
27
DELISTED
Intersect ENT, Inc
XENT
| $47.5M | 1.51% |
1,268,850
+804,000
| +173% | +$31.6M |
|
|
CERN
28
DELISTED
Cerner Corp
CERN
| $45.6M | 1.45% |
+761,940
| New | +$45.1M |
|
|
DVAX
29
DELISTED
Dynavax Technologies
DVAX
| $38.6M | 1.23% |
2,531,107
+1,212,495
| +92% | +$21M |
|
|
MDCO
30
DELISTED
Medicines Co
MDCO
| $36.8M | 1.17% |
1,003,948
+18,726
| +2% | +$608K |
|
31
Centene
CNC
$30.1B
| $36.1M | 1.15% |
+586,360
| New | +$33.8M |
|
32
PUT
Invesco QQQ Trust
QQQ
$450B
| $35.2M | 1.12% |
+205,000
| New | +$34.4M |
|
|
EXAS
33
DELISTED
Exact Sciences
EXAS
| $34.2M | 1.09% |
+572,240
| New | +$30.8M |
|
34
CALL
Bristol-Myers Squibb
BMY
$132B
| $27.7M | 0.88% |
+500,000
| New | +$27M |
|
|
35
Bristol-Myers Squibb
BMY
$132B
| $27M | 0.86% |
488,750
-112,330
| -19% | -$6.07M |
|
|
CELG
36
CALL
DELISTED
Celgene Corp
CELG
| $23.8M | 0.76% |
300,000
| – | – |
|
37
Boston Scientific
BSX
$68.4B
| $23.1M | 0.74% |
707,860
+134,380
| +23% | +$4.05M |
|
38
Stryker
SYK
$133B
| $17.9M | 0.57% |
+106,290
| New | +$17.9M |
|
|
CVRS
39
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $16.5M | 0.52% |
19,981,655
| – | – |
|
40
PUT
Baxter International
BAX
$13.8B
| $14.8M | 0.47% |
+200,000
| New | +$14.1M |
|
|
HOLX
41
DELISTED
Hologic
HOLX
| $13.8M | 0.44% |
+345,900
| New | +$13.3M |
|
|
AGN
42
DELISTED
Allergan plc
AGN
| $11M | 0.35% |
66,210
-225,310
| -77% | -$36.2M |
|
43
Amgen
AMGN
$209B
| $9.51M | 0.3% |
+51,510
| New | +$9.11M |
|
44
Viatris
VTRS
$20.7B
| $5.85M | 0.19% |
+161,930
| New | +$6.35M |
|
|
PTE
45
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $5.76M | 0.18% |
+9,783
| New | +$5.82M |
|
46
Tenet Healthcare
THC
$20.3B
| $5.29M | 0.17% |
+157,550
| New | +$4.9M |
|
|
PDCO
47
PUT
DELISTED
Patterson Companies, Inc.
PDCO
| $4.53M | 0.14% |
+200,000
| New | +$4.51M |
|
|
ZSAN
48
DELISTED
Zosano Pharma Corporation
ZSAN
| $2.27M | 0.07% |
15,869
+155
| +1% | +$23.3K |
|
49
Myriad Genetics
MYGN
$507M
| $2.18M | 0.07% |
+58,335
| New | +$1.97M |
|
|
50
Agilent Technologies
A
$39.2B
| – | – |
-1,054,000
| Closed | -$70.5M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q2 2018 Portfolio in Review
As of Q2 2018, HealthCor Management held 67 positions worth $3.15B, up 7.1% from $2.94B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
HealthCor Management's Q2 2018 filing shows 21 new, 15 increased, 10 reduced and 18 closed positions. Its largest new stake was HCA Healthcare: 1,200,000 shares worth $123M. The largest sale was Dentsply Sirona, an estimated $145M.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 90% a quarter earlier.
- HealthCor Management's largest Q2 2018 buy was HCA Healthcare: 1,200,000 shares worth $123M.
- HealthCor Management added most to Elevance Health in Q2 2018, an estimated $94.1M increase.
- HealthCor Management's biggest Q2 2018 reduction was UnitedHealth, cutting an estimated $51.3M.
- HealthCor Management fully exited Dentsply Sirona in Q2 2018, selling an estimated $145M.
- HealthCor Management's ten largest holdings make up 50% of its $3.15B portfolio in Q2 2018.
- HealthCor Management opened 21 new positions and closed 18 in Q2 2018.
- HealthCor Management's portfolio value rose 7.1% quarter-over-quarter to $3.15B.
Based on HealthCor Management's 13F filing for Q2 2018, filed 14 Aug 2018.